White label ELPA - ClinicalTrials.eu

Study on Avibactam and Drug Combination for Treating Severe Infections in Patients

Not recruiting

3 1 1 1
Investigated diseases:
- Sepsis
Investigated drugs:
Study of Pembrolizumab and BCG for Patients with High-Risk Non-Muscle Invasive Bladder Cancer

Not recruiting

3 1 1 1
Investigated diseases:
- Bladder cancer
Investigated drugs:
- Bacillus Calmette-Guérin (Bcg), Tice
- Pembrolizumab
+7
Study on the Effects of S-217622 for Adults Hospitalized with COVID-19

Not recruiting

3 1
Investigated diseases:
- COVID-19
Investigated drugs:
- (6E)-6-[(6-Chloro-2-Methyl-2H-Indazol-5-Yl)Imino]-3-[(1-Methyl-1H-1,2,4-Triazol-3-Yl)Methyl]-1-[(2,4,5-Trifluorophenyl)Methyl]-1,3,5-Triazinane-2,4-Dione
Study Comparing Nivolumab with Ipilimumab or Nivolumab with Chemotherapy to Chemotherapy Alone in Patients with Early Stage Non-Small Cell Lung Cancer

Not recruiting

3 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
Study on the Effects of Dimethyl Fumarate for Patients with Friedreich’s Ataxia

Not recruiting

2 1 1
Investigated diseases:
- Friedreich’s ataxia
Investigated drugs:
- Dimethyl Fumarate
Study on the Effectiveness and Safety of Imipenem, Cilastatin, and XNW4107 for Adults with Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia

Not recruiting

3 1 1 1
Investigated diseases:
- Pneumonia bacterial
Investigated drugs:
Study on the Effects of Guselkumab on Memory T-Cells in Psoriasis Patients

Not recruiting

3 1 1 1
Investigated diseases:
- Psoriasis
Investigated drugs:
- Guselkumab
Study on Metreleptin for Children Under 6 with Generalized Lipodystrophy and Related Diabetes or High Triglycerides

Not recruiting

3 1 1 1
Investigated diseases:
- Congenital generalised lipodystrophy
Investigated drugs:
- Metreleptin
Study Comparing ARV-471 and Fulvestrant for Patients with Advanced Estrogen Receptor-Positive, HER2-Negative Breast Cancer After Endocrine Treatment

Not recruiting

3 1 1 1
Investigated diseases:
- Breast cancer
Investigated drugs:
- (3S)-3-[6-[4-[[1-[4-[(1R,2S)-6-Hydroxy-2-Phenyl-1,2,3,4-Tetrahydronaphthalen-1-Yl]Phenyl]Piperidin-4-Yl]Methyl]Piperazin-1-Yl]-3-Oxo-1H-Isoindol-2-Yl]Piperidine-2,6-Dione
- Fulvestrant
+9
Study on AUP1602-C for Treating Non-Healing Diabetic Foot Ulcers in Patients

Not recruiting

2 1
Investigated diseases:
- Diabetic foot
Investigated drugs:
- Aup1602-C

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies